本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Innate Pharma SA

2.04
+0.04502.26%
成交量:1.87萬
成交額:3.74萬
市值:1.71億
市盈率:-4.51
高:2.05
開:1.99
低:1.96
收:2.00
資料載入中...

公司資料

公司名字:
Innate Pharma SA
交易所:
NASDAQ
成立時間:
1999
員工人數:
168
公司地址:
117, Avenue de Luminy,BP 30191,Marseille,Provence-Alpes-Côte d'Azur,France
郵編:
13009
傳真:
33 4 30 30 30 00
簡介:
Innate Pharma S.A.成立於1999年9月23日,是一家生物技術公司,致力於發現,開發和商業化一流的治療性抗體,這些抗體旨在利用免疫系統來治療嚴重未滿足醫療需求的腫瘤適應症。該公司在免疫腫瘤學的研究和開發方面擁有豐富的經驗,是了解自然殺傷細胞或NK細胞生物學的先驅。

董事

名稱
職位
Herve Brailly
Chairman of the Supervisory Board
Irina Staatz Granzer
Member and Vice Chairman of the Supervisory Board
Mondher Mahjoubi
Chairman of the Executive Board, Chief Executive Officer
Gilles Brisson
Member of the Supervisory Board
Jean Yves Blay
Member of the Supervisory Board
Laure Helene Mercier
Director, EVP, Chief Financial Officer
Mailys Ferrere
Member of the Supervisory Board
Marcus Schindler
Member of the Supervisory Board
Patrick Langlois
Member of the Supervisory Board
Veronique Chabernaud
Member of the Supervisory Board
Yannis Morel
Director, EVP, Product Portfolio Strategy and Business Development

股東

名稱
職位
Mondher Mahjoubi
Chairman of the Executive Board, Chief Executive Officer
Laure Helene Mercier
Director, EVP, Chief Financial Officer
Eric Vivier
SVP, Chief Scientific Officer
Frederique Brune
VP Development, CMC and Supply Chain
Jennifer Butler
EVP, U.S. General Manager of Innate Pharma US Inc.
Odile Belzunce
VP Compliance, IT and Portfolio Management
Pierre Dodion
EVP, Chief Medical Officer
Tracy Rossin
VP, Global Head of Communications
Yannis Morel
Director, EVP, Product Portfolio Strategy and Business Development